Thrombogenics
Get Full AccessDescription
- ThromboGenics is an integrated biopharmaceutical company focused on developing and commercializing next generation treatments for diabetic eye disease. ThromboGenics lead product is JETREA® (ocriplasmin), globally the first and only pharmacological solution for the treatment of symptomatic vitreomacular adhesion/ vitreomacular traction. ThromboGenics inc, the US subsidiary of ThromboGenics nv, is commercialising JETREA in the US, where the drug is indicated for the treatment of symptomatic vitreomacular adhesion. Alcon, a division of Novartis, is commercializing JETREA® outside the United States. ThromboGenics is headquartered in Leuven, Belgium, and has offices in Iselin, NJ (US) and Dublin, Ireland. The Company is listed on the NYSE Euronext Brussels exchange under the symbol THR. More information is available at www.thrombogenics.com.
-
Headquarters:Bausch + Lomb 700 Route 202/20 , Bridgewater, New Jersey, United States
More -
Phone Number: +1 321-675-1310
-
Website: https://www.thrombogenics.com
-
Employees:74
-
Revenue:$50 - 100M
-
Legal Name:Thrombogenics
-
Thrombogenics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Thrombogenics
-
Where are Thrombogenics's Headquarters?
Thrombogenics's Headquarters are in Bausch + Lomb 700 Route 202/20 ,Bridgewater,New Jersey,United States
-
What is Thrombogenics's phone number?
Thrombogenics's phone number is +1 321-675-1310
-
What is Thrombogenics's official website?
Thrombogenics's official website is https://www.thrombogenics.com
-
What is Thrombogenics's Revenue?
Thrombogenics's revenue is $50 - 100M
-
What is Thrombogenics's NAICS code?
Thrombogenics's NAICS code is 541713
-
How many employees are working in Thrombogenics
Thrombogenics has 74 employees
-
What is Thrombogenics's Industry?
Thrombogenics is in the industry of Biotechnology